What are the European Respiratory Society (ERS) guidelines for use of bronchodilators in the treatment of bronchiectasis?

Updated: Sep 15, 2020
  • Author: Ethan E Emmons, MD; Chief Editor: Zab Mosenifar, MD, FACP, FCCP  more...
  • Print

Routinely offering long-acting bronchodilators is not suggested for adult patients with bronchiectasis. Offer long-acting bronchodilators for patients with significant breathlessness on an individual basis. Use of bronchodilators is suggested (1) before physiotherapy, (2) before inhaled mucoactive drugs, and (3) before inhaled antibiotics, in order to increase tolerability and optimize pulmonary deposition in diseased areas of the lungs. Again, however, it is suggested that the diagnosis of bronchiectasis should not affect the use of long-acting bronchodilators in patients with comorbid asthma or COPD.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!